<?xml-stylesheet type='text/xsl' href='ctgovTransform.xsl'?>
<CT.GOV_Trial requestNumber="4894">
  <stage>Registered</stage>
  <submitdate>18/12/2013</submitdate>
  <approvaldate>18/12/2013</approvaldate>
  <nctid>NCT02019264</nctid>
  <trial_identification>
    <studytitle>A Study to Evaluate the Effect of Long-term Treatment With BELVIQ (Lorcaserin HCl) on the Incidence of Major Adverse Cardiovascular Events and Conversion to Type 2 Diabetes Mellitus in Obese and Overweight Subjects With Cardiovascular Disease or Multiple Cardiovascular Risk Factors</studytitle>
    <scientifictitle>A Randomized, Double-blind, Placebo-controlled, Parallel-group Study to Evaluate the Effect of Long-term Treatment With BELVIQ (Lorcaserin HCl) on the Incidence of Major Adverse Cardiovascular Events and Conversion to Type 2 Diabetes Mellitus in Obese and Overweight Subjects With Cardiovascular Disease or Multiple Cardiovascular Risk Factors</scientifictitle>
    <utrn />
    <trialacronym>CAMELLIA-TIMI</trialacronym>
    <secondaryid>2013-000324-34</secondaryid>
    <secondaryid>APD356-G000-401</secondaryid>
  </trial_identification>
  <conditions>
    <healthcondition>Cardiovascular Disease</healthcondition>
    <healthcondition>High Cardiovascular Risk</healthcondition>
    <healthcondition>Obesity</healthcondition>
    <healthcondition>Overweight</healthcondition>
    <healthcondition>Type 2 Diabetes</healthcondition>
    <conditioncode>
      <conditioncode1>Metabolic and Endocrine</conditioncode1>
      <conditioncode2>Diabetes</conditioncode2>
    </conditioncode>
    <conditioncode>
      <conditioncode1>Diet and Nutrition</conditioncode1>
      <conditioncode2>Obesity</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>Treatment: drugs - APD356-Lorcaserin hydrochloride
Treatment: drugs - Placebo

Experimental: APD356 10 mg - APD356 10 mg twice daily

Placebo Comparator: Placebo - Placebo twice daily


Treatment: drugs: APD356-Lorcaserin hydrochloride
APD356 10 mg twice daily

Treatment: drugs: Placebo
Placebo twice daily

</interventions>
    <comparator />
    <control />
    <interventioncode>Treatment: drugs</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>Time from randomization to first occurrence of Major Adverse Cardiovascular Events (MACE) - MACE events include: myocardial infarction, stroke and cardiovascular (CV) death</outcome>
      <timepoint>Up to 5 years</timepoint>
    </primaryOutcome>
    <primaryOutcome>
      <outcome>Time from randomization to conversion to type 2 diabetes mellitus (T2DM) for subjects without any type of diabetes at Baseline</outcome>
      <timepoint>Baseline, and specified timepoints up to 5 years</timepoint>
    </primaryOutcome>
    <primaryOutcome>
      <outcome>Time from randomization to first occurrence of MACE+ - MACE+ events include: myocardial infarction, stroke, CV death, and hospitalization due to unstable angina, heart failure, or any coronary revascularization</outcome>
      <timepoint>Up to 5 years</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>Time from randomization to event of each component of MACE+</outcome>
      <timepoint>Up to 5 years</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Time from randomization to event of all-cause mortality</outcome>
      <timepoint>Up to 5 years</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Time from randomization to event of new onset renal impairment or worsening existing renal impairment in subjects with T2DM at Baseline - New onset renal impairment or worsening existing renal impairment include the first occurrence of microalbuminuria, macroalbuminuria, worsening of albuminuria, newly developed CKD, or worsening of CKD, doubling of serum creatinine, or any of the following: ESRD, renal transplant, and renal death.</outcome>
      <timepoint>Up to 5 years</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Time from randomization to event of improvement in renal function</outcome>
      <timepoint>Up to 5 years</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Change from Baseline in HbA[1c] at 6 months in subjects with T2DM at Baseline</outcome>
      <timepoint>Baseline and 6 months</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>The proportion of subjects who meet FDA-defined valvulopathy in echocardiographically determined heart valve changes - Comparison between lorcaserin HCl and placebo will be made at 1 year.</outcome>
      <timepoint>Baseline and 1 year</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>The percent change from Baseline in echocardiographically-determined pulmonary arterial systolic pressure - Comparison between lorcaserin HCl and placebo will be made at 1 year.</outcome>
      <timepoint>Baseline and 1 year</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Time to conversion to normal glucose homeostasis</outcome>
      <timepoint>Baseline and 1 year</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>Inclusion Criteria

          1. BMI greater than or equal to 27 kg/m^2

          2. Subjects able and willing to comply with a reduced-calorie diet and an increased
             physical activity program

          3. Age greater than or equal to 40 years with established CV disease as defined by one of
             the following:

               1. History of documented MI or ischemic stroke

               2. History of peripheral artery disease

               3. History of revascularization (coronary, carotid, or peripheral artery)

               4. Significant unrevascularized coronary arterial stenosis

        OR

        Age greater than or equal to 55 years for women or greater than or equal to 50 years for
        men who have T2DM without established CV disease plus at least one of the following CV risk
        factors:

          1. Hypertension, or currently receiving therapy for documented hypertension

          2. Dyslipidemia, or currently taking prescription lipid-lowering therapy for documented
             dyslipidemia

          3. Calculated creatinine clearance greater than or equal to 30 to less than or equal to
             60 mL/min per the Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) equation

          4. High hsCRP

          5. Urinary albumin-to-creatinine ratio (ACR) greater than or equal to 30 ug/mg

        Subjects with T2DM may have a pre-existing or new diagnosis of T2DM. A new diagnosis of
        T2DM (ie, discovered at Screening) should be based on the 2013 American Diabetes
        Association (ADA) guidelines.

        All T2DM subjects must have an HbA[1c] less than 10% at Screening. If subjects are being
        treated, or upon diagnosis need to be treated with antidiabetic agents, the T2DM treatment
        regimen must be stable for at least 3 months prior to randomization.</inclusivecriteria>
    <inclusiveminage>40</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage />
    <inclusivemaxagetype>No limit</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>Exclusion Criteria

          1. Moderate or greater symptoms of congestive cardiac failure (New York Heart Association
             [NYHA] class III or IV)

          2. Known left ventricular (LV) ejection fraction less than 20%

          3. Moderate or greater symptoms of pulmonary hypertension (PH)

          4. Known severe valvular disease Moderate renal impairment, severe renal impairment, or
             end stage renal disease (ESRD) (calculated creatinine clearance less than 30 mL/min
             per the CKD-EPI equation based on ideal body weight)

          5. Severe hepatic impairment

          6. Use of other products intended for weight loss including prescription drugs,
             over-the-counter (OTC) drugs, and herbal preparations

          7. Use of more than one other serotonergic drug

          8. Use of drugs known to increase the risk for cardiac valvulopathy prior to Screening
             including, but not limited to: cyproheptadine, amoxapine, TCAs, mirtazapine,
             pergolide, ergotamine, methysergide, cabergoline

          9. History or evidence of clinically significant disease (e.g., malignancy, cardiac,
             respiratory, gastrointestinal, renal or psychiatric disease)

         10. Use of lorcaserin HCl prior to Screening or hypersensitivity to lorcaserin HCl or any
             of the excipients

         11. Planned bariatric surgery

         12. Females must not be breastfeeding or pregnant</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Treatment</purpose>
    <allocation>Randomised controlled trial</allocation>
    <concealment />
    <sequence />
    <masking>Blinded (masking used)</masking>
    <assignment>Parallel</assignment>
    <designfeatures />
    <endpoint />
    <statisticalmethods />
    <masking1>The people receiving the treatment/s</masking1>
    <masking2 />
    <masking3 />
    <masking4>The people analysing the results/data</masking4>
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase>Phase 4</phase>
    <anticipatedstartdate />
    <actualstartdate>1/01/2014</actualstartdate>
    <anticipatedenddate />
    <actualenddate />
    <samplesize />
    <actualsamplesize>12000</actualsamplesize>
    <recruitmentstatus>Active, not recruiting</recruitmentstatus>
    <anticipatedlastvisitdate>1/11/2018</anticipatedlastvisitdate>
    <actuallastvisitdate />
    <dataanalysis />
    <withdrawnreason />
    <withdrawnreasonother />
    <recruitmentcountry>Australia</recruitmentcountry>
    <recruitmentstate>NSW,QLD,SA,VIC,WA</recruitmentstate>
    <hospital> - Coffs Harbour</hospital>
    <hospital> - Gosford</hospital>
    <hospital> - Wollongong</hospital>
    <hospital> - Auchenflower</hospital>
    <hospital> - Brisbane</hospital>
    <hospital> - Herston</hospital>
    <hospital> - Milton</hospital>
    <hospital> - Sherwood</hospital>
    <hospital> - Southport, QLD</hospital>
    <hospital> - Adelaide</hospital>
    <hospital> - Ashford</hospital>
    <hospital> - Elizabeth Vale</hospital>
    <hospital> - Fullarton</hospital>
    <hospital> - Woodville South</hospital>
    <hospital> - Ballarat</hospital>
    <hospital> - East St Kilda</hospital>
    <hospital> - Geelong</hospital>
    <hospital> - Heidelberg</hospital>
    <hospital> - Fremantle</hospital>
    <hospital> - Joondalup</hospital>
    <hospital> - Murdoch</hospital>
    <hospital> - Liverpool</hospital>
    <postcode> - Coffs Harbour</postcode>
    <postcode> - Gosford</postcode>
    <postcode> - Wollongong</postcode>
    <postcode> - Auchenflower</postcode>
    <postcode> - Brisbane</postcode>
    <postcode> - Herston</postcode>
    <postcode> - Milton</postcode>
    <postcode> - Sherwood</postcode>
    <postcode> - Southport, QLD</postcode>
    <postcode> - Adelaide</postcode>
    <postcode> - Ashford</postcode>
    <postcode> - Elizabeth Vale</postcode>
    <postcode> - Fullarton</postcode>
    <postcode> - Woodville South</postcode>
    <postcode> - Ballarat</postcode>
    <postcode> - East St Kilda</postcode>
    <postcode> - Geelong</postcode>
    <postcode> - Heidelberg</postcode>
    <postcode> - Fremantle</postcode>
    <postcode> - Joondalup</postcode>
    <postcode> - Murdoch</postcode>
    <postcode> - Liverpool</postcode>
    <countryoutsideaustralia>
      <country>United States</country>
      <state>Alabama</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>United States</country>
      <state>Alaska</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>United States</country>
      <state>Arizona</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>United States</country>
      <state>Arkansas</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>United States</country>
      <state>California</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>United States</country>
      <state>Colorado</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>United States</country>
      <state>Connecticut</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>United States</country>
      <state>Delaware</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>United States</country>
      <state>Florida</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>United States</country>
      <state>Georgia</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>United States</country>
      <state>Illinois</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>United States</country>
      <state>Indiana</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>United States</country>
      <state>Iowa</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>United States</country>
      <state>Kansas</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>United States</country>
      <state>Kentucky</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>United States</country>
      <state>Maine</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>United States</country>
      <state>Maryland</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>United States</country>
      <state>Massachusetts</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>United States</country>
      <state>Michigan</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>United States</country>
      <state>Minnesota</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>United States</country>
      <state>Mississippi</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>United States</country>
      <state>Missouri</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>United States</country>
      <state>Montana</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>United States</country>
      <state>Nebraska</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>United States</country>
      <state>Nevada</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>United States</country>
      <state>New Jersey</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>United States</country>
      <state>New Mexico</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>United States</country>
      <state>New York</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>United States</country>
      <state>North Carolina</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>United States</country>
      <state>North Dakota</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>United States</country>
      <state>Ohio</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>United States</country>
      <state>Oklahoma</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>United States</country>
      <state>Pennsylvania</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>United States</country>
      <state>Rhode Island</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>United States</country>
      <state>South Carolina</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>United States</country>
      <state>South Dakota</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>United States</country>
      <state>Tennessee</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>United States</country>
      <state>Texas</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>United States</country>
      <state>Utah</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>United States</country>
      <state>Virginia</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>United States</country>
      <state>Washington</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>United States</country>
      <state>Wisconsin</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Bahamas</country>
      <state>Nassau</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Canada</country>
      <state>Alberta</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Canada</country>
      <state>British Columbia</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Canada</country>
      <state>Nova Scotia</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Canada</country>
      <state>Ontario</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Canada</country>
      <state>Quebec</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Chile</country>
      <state>Araucania</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Chile</country>
      <state>Santiago</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Chile</country>
      <state>Concepcion</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Mexico</country>
      <state>Jalisco</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Mexico</country>
      <state>Nuevo Leon</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Mexico</country>
      <state>Veracruz</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Mexico</country>
      <state>Aguascalientes</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Mexico</country>
      <state>Distrito Federal</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>New Zealand</country>
      <state>Auckland</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>New Zealand</country>
      <state>Canterbury</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>New Zealand</country>
      <state>Otago</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>New Zealand</country>
      <state>Taranaki</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>New Zealand</country>
      <state>Wellington</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>New Zealand</country>
      <state>Hastings</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>New Zealand</country>
      <state>Nelson</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>New Zealand</country>
      <state>Rotorua</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>New Zealand</country>
      <state>Tauranga</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Poland</country>
      <state>Bezrzecze</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Poland</country>
      <state>Biala Rawska</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Poland</country>
      <state>Bialystok</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Poland</country>
      <state>Bydgoszcz</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Poland</country>
      <state>Chorzow</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Poland</country>
      <state>Chrzanow</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Poland</country>
      <state>Gdynia</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Poland</country>
      <state>Inowroclaw</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Poland</country>
      <state>Kamieniec Zabkowicki</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Poland</country>
      <state>Koluszki</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Poland</country>
      <state>Krakow</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Poland</country>
      <state>Legnica</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Poland</country>
      <state>Lodz</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Poland</country>
      <state>Lublin</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Poland</country>
      <state>Mragowo</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Poland</country>
      <state>Olsztyn</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Poland</country>
      <state>Piotrkow Trybunalski</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Poland</country>
      <state>Plock</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Poland</country>
      <state>Poznan</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Poland</country>
      <state>Szczecin</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Poland</country>
      <state>Tarnow</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Poland</country>
      <state>Teczna</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Poland</country>
      <state>Todz</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Poland</country>
      <state>Torun</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Poland</country>
      <state>Warszawa</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Poland</country>
      <state>Wierzchoslawice</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Poland</country>
      <state>Wloclawek</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Poland</country>
      <state>Wroclaw</state>
    </countryoutsideaustralia>
  </recruitment>
  <sponsorship>
    <primarysponsortype>Commercial sector/Commercial sector/Industry</primarysponsortype>
    <primarysponsorname>Eisai Inc.</primarysponsorname>
    <primarysponsoraddress />
    <primarysponsorcountry />
    <othercollaborator>
      <othercollaboratortype>Other</othercollaboratortype>
      <othercollaboratorname>Thrombolysis In Myocardial Infarction (TIMI) Academic Research Organization</othercollaboratorname>
      <othercollaboratoraddress />
      <othercollaboratorcountry />
    </othercollaborator>
  </sponsorship>
  <ethicsAndSummary>
    <summary>This is a multicenter, randomized, double-blind, placebo-controlled, parallel-group study in
      overweight and obese subjects with CV disease and/or multiple CV risk factors.</summary>
    <trialwebsite>https://clinicaltrials.gov/show/NCT02019264</trialwebsite>
    <publication />
    <ethicsreview />
    <publicnotes />
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Principal Investigator</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Public Queries</type>
    </contact>
  </contacts>
</CT.GOV_Trial>